The history of Viagra presents a intricate picture for those considering investment. While the initial introduction generated significant gains, the expiration of its patent opened the door to cheaper alternatives, dramatically eroding market share. This creates a particular challenge for pharmaceutical companies depending on similar blockbuster me
Viagra and Big Pharma: A Uncertain Venture ?
The legacy of Viagra, and its creator copyright, presents a complex case study for investors. At first a blockbuster drug, generating billions in income, its exclusivity period created a deluge of lower-priced alternatives , significantly eroding its dominance. While certain firms may seek to capitalize on male sexual dysfunction, the current lands